8-K Announcements
6Material company update
May 11, 2026·SEC
Material company update
May 7, 2026·SEC
Material company update
Apr 6, 2026·SEC
STERIS plc(STE)Earnings, Financials & Key Ratios
STE•NYSE
25.5× P/E·Price updated Jun 19, 2026
AboutSTERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.Show more
- Revenue$5.94B+8.7%
- EBITDA$1.1B-18.0%
- Net Income$785M+27.7%
- EPS (Diluted)7.93+27.9%
- Gross Margin44.25%+0.5%
- EBITDA Margin18.56%-24.5%
- Operating Margin18.56%+16.9%
- Net Margin13.23%+17.5%
- ROE11.37%+19.6%
STE Key Insights
STERIS plc (STE) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 9/9
- ✓FCF machine: 16.4% free cash flow margin
- ✓21 consecutive years of dividend growth
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 13.8%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when STE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
STE Price & Volume
STERIS plc (STE) stock price & volume — 10-year historical chart
Loading chart...
STE Growth Metrics
STERIS plc (STE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years10.24%
5 Years13.82%
3 Years9.38%
TTM8.73%
Profit CAGR
10 Years21.63%
5 Years14.59%
3 Years94.3%
TTM27.29%
EPS CAGR
10 Years17.66%
5 Years11.36%
3 Years94.97%
TTM27.9%
Return on Capital
10 Years8.6%
5 Years8.52%
3 Years9.7%
Last Year11.77%
STE Recent Earnings
STERIS plc (STE) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 8/12 qtrs (67%)
Q2 2026Latest
May 11, 2026Metric
Actual
Est
EPS
$2.83-0.7%
$2.85
Rev
$1.6B-0.4%
$1.6B
Q1 2026
Feb 4, 2026Metric
Actual
Est
EPS
$2.53+0.0%
$2.53
Rev
$1.5B+1.0%
$1.5B
Q4 2025
Nov 5, 2025Metric
Actual
Est
EPS
$2.47+5.1%
$2.35
Rev
$1.5B+2.0%
$1.4B
Q3 2025
Aug 6, 2025Metric
Actual
Est
EPS
$2.34+3.5%
$2.26
Rev
$1.4B+2.1%
$1.4B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 11, 2026 | $2.83vs $2.85-0.7% | $1.6Bvs $1.6B-0.4% |
| Q1 2026 | Feb 4, 2026 | $2.53vs $2.53+0.0% | $1.5Bvs $1.5B+1.0% |
| Q4 2025 | Nov 5, 2025 | $2.47vs $2.35+5.1% | $1.5Bvs $1.4B+2.0% |
| Q3 2025 | Aug 6, 2025 | $2.34vs $2.26+3.5% | $1.4Bvs $1.4B+2.1% |
Based on last 12 quarters of dataView full earnings history →
STE Peer Comparison
STERIS plc (STE) competitors in Device suppliers, distribution, and services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 WAT | 23.17B | 355.44 | 33.03 | 6.99% | 11.91% | 8.04% | 0.55 | |
 MMSI | 4.01B | 67.22 | 31.56 | 11.66% | 9.03% | 8.95% | 0.57 | |
 HSIC | 9.17B | 79.92 | 24.44 | 4.03% | 3.02% | 8.24% | 0.77 | |
 IART | 1.37B | 17.58 | -2.61 | 1.53% | -30.15% | -47.65% | 1.95 | |
 CNMD | 1B | 32.58 | 21.58 | 5.16% | 4% | 5.4% | 0.81 | |
 SHC | 4.51B | 15.82 | 58.59 | 5.74% | 9.91% | 20.57% | 3.75 | |
 BDX | 52.16B | 143.98 | 24.70 | 8.23% | 5.33% | 4.54% | 0.76 | |
 BAX | 10.27B | 19.89 | -11.37 | 5.72% | -9.7% | -16.5% | 1.64 |
Compare STE vs Peers
STERIS plc (STE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
STE Income Statement
STERIS plc (STE) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 2.62B | 2.78B | 3.03B | 3.11B | 4.22B | 4.54B | 5.14B | 5.46B | 5.94B |
Revenue Growth % | 0.28% | 6.19% | 8.94% | 2.53% | 35.91% | 7.41% | 13.28% | 6.24% | 8.73% |
Cost of Goods Sold | 1.53B | 1.61B | 1.71B | 1.76B | 2.34B | 2.56B | 2.92B | 3.06B | 3.31B |
COGS % of Revenue | 58.29% | 57.77% | 56.45% | 56.78% | 55.41% | 56.34% | 56.83% | 55.99% | 55.75% |
Gross Profit | 1.09B▲ 0% | 1.17B▲ 7.5% | 1.32B▲ 12.3% | 1.34B▲ 1.8% | 1.88B▲ 40.2% | 1.98B▲ 5.2% | 2.22B▲ 12.0% | 2.4B▲ 8.3% | 2.63B▲ 9.3% |
Gross Margin % | 41.71% | 42.23% | 43.55% | 43.22% | 44.59% | 43.66% | 43.17% | 44.01% | 44.25% |
Gross Profit Growth % | 6.48% | 7.53% | 12.34% | 1.75% | 40.2% | 5.19% | 11.99% | 8.32% | 9.31% |
Operating Expenses | 692.86M | 763.96M | 782.95M | 794.73M | 1.41B | 1.19B | 1.38B | 1.54B | 1.52B |
OpEx % of Revenue | 26.45% | 27.46% | 25.83% | 25.57% | 33.27% | 26.22% | 26.89% | 28.14% | 25.69% |
Selling, General & Admin | 631.98M | 669.94M | 716.73M | 731.32M | 1.32B | 1.09B | 1.25B | 1.33B | 1.41B |
SG&A % of Revenue | 24.12% | 24.08% | 23.65% | 23.53% | 31.22% | 24.04% | 24.37% | 24.44% | 23.71% |
Research & Development | 60.78M | 63.04M | 65.55M | 66.33M | 86.66M | 98.48M | 103.68M | 107.65M | 112.9M |
R&D % of Revenue | 2.32% | 2.27% | 2.16% | 2.13% | 2.05% | 2.17% | 2.02% | 1.97% | 1.9% |
Other Operating Expenses | 103K | 30.99M | 673K | -2.91M | 48K | 485K | 26.05M | 94.2M | 4.1M |
Operating Income | 399.88M▲ 0% | 411.02M▲ 2.8% | 537.05M▲ 30.7% | 548.37M▲ 2.1% | 477.81M▼ 12.9% | 791.1M▲ 65.6% | 836.12M▲ 5.7% | 866.64M▲ 3.7% | 1.1B▲ 27.1% |
Operating Margin % | 15.26% | 14.77% | 17.72% | 17.65% | 11.31% | 17.44% | 16.27% | 15.87% | 18.56% |
Operating Income Growth % | 76.78% | 2.79% | 30.66% | 2.11% | -12.87% | 65.57% | 5.69% | 3.65% | 27.13% |
EBITDA | 578.22M | 636.95M | 734.28M | 767.61M | 1.03B | 1.34B | 1.4B | 1.34B | 1.1B |
EBITDA Margin % | 22.07% | 22.89% | 24.23% | 24.7% | 24.41% | 29.63% | 27.27% | 24.6% | 18.56% |
EBITDA Growth % | 39.55% | 10.16% | 15.28% | 4.54% | 34.3% | 30.37% | 4.27% | -4.17% | -17.95% |
D&A (Non-Cash Add-back) | 178.33M | 225.92M | 197.24M | 219.24M | 553.1M | 552.9M | 565.24M | 476.21M | 0 |
EBIT | 405.61M | 414.04M | 539.03M | 554.71M | 456.29M | 791.1M | 847.16M | 882.47M | 1.1B |
Net Interest Income | -44.9M | -41.99M | -38.29M | -30.84M | -83.21M | -110.83M | -133.31M | -77.86M | -60.7M |
Interest Income | 5.73M | 3.02M | 1.99M | 6.34M | 6.28M | 0 | 11.04M | 8.4M | 0 |
Interest Expense | 50.63M | 45.02M | 40.28M | 37.18M | 89.49M | 110.83M | 144.35M | 86.26M | 60.7M |
Other Income/Expense | -44.9M | -41.99M | -38.29M | -30.84M | -111.01M | -110.83M | -133.31M | -70.43M | -54.5M |
Pretax Income | 354.98M▲ 0% | 369.03M▲ 4.0% | 498.75M▲ 35.2% | 517.53M▲ 3.8% | 366.8M▼ 29.1% | 680.27M▲ 85.5% | 702.81M▲ 3.3% | 796.21M▲ 13.3% | 1.05B▲ 31.5% |
Pretax Margin % | 13.55% | 13.26% | 16.46% | 16.65% | 8.69% | 15% | 13.68% | 14.58% | 17.64% |
Income Tax | 63.36M | 64.28M | 90.89M | 120.66M | 82.34M | 124.07M | 149.53M | 184.65M | 262.2M |
Effective Tax Rate % | 17.85% | 17.42% | 18.22% | 23.32% | 22.45% | 18.24% | 21.28% | 23.19% | 25.04% |
Net Income | 290.92M▲ 0% | 304.05M▲ 4.5% | 407.66M▲ 34.1% | 397.4M▼ 2.5% | 243.89M▼ 38.6% | 107.03M▼ 56.1% | 378.24M▲ 253.4% | 614.64M▲ 62.5% | 785.1M▲ 27.7% |
Net Margin % | 11.1% | 10.93% | 13.45% | 12.79% | 5.77% | 2.36% | 7.36% | 11.26% | 13.23% |
Net Income Growth % | 164.55% | 4.52% | 34.08% | -2.52% | -38.63% | -56.12% | 253.4% | 62.5% | 27.73% |
Net Income (Continuing) | 291.62M | 305.08M | 407.86M | 396.87M | 284.46M | 556.2M | 553.28M | 611.56M | 785.1M |
Discontinued Operations | 0 | 0 | 0 | 0 | -41.59M | -450.38M | -173.2M | 4.52M | 0 |
Minority Interest | 11.34M | 7.99M | 12.85M | 10.48M | 12.28M | 9.97M | 13.18M | 12.35M | 0 |
EPS (Diluted) | 3.39▲ 0% | 3.56▲ 5.0% | 4.76▲ 33.7% | 4.63▼ 2.7% | 2.48▼ 46.4% | 1.07▼ 56.9% | 3.81▲ 256.1% | 6.20▲ 62.7% | 7.93▲ 27.9% |
EPS Growth % | 164.84% | 5.01% | 33.71% | -2.73% | -46.44% | -56.85% | 256.07% | 62.73% | 27.9% |
EPS (Basic) | 3.42 | 3.59 | 4.81 | 4.66 | 2.50 | 1.07 | 3.83 | 6.24 | 7.93 |
Diluted Shares Outstanding | 85.71M | 85.47M | 85.64M | 85.9M | 98.33M | 100.25M | 99.36M | 99.07M | 98.7M |
Basic Shares Outstanding | 85.03M | 84.58M | 84.78M | 85.2M | 97.53M | 99.71M | 98.79M | 98.58M | 98.2M |
Dividend Payout Ratio | 35.38% | 37% | 30.18% | 33.68% | 66.9% | 171.45% | 53.03% | 35.77% | 30.8% |
STE Balance Sheet
STERIS plc (STE) balance sheet — assets, liabilities & shareholders' equity
| Metric | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 989.66M | 1.05B | 1.22B | 1.21B | 1.88B | 2.01B | 2.87B | 2B | 2.39B |
Cash & Short-Term Investments | 201.53M | 220.63M | 319.58M | 220.53M | 348.32M | 208.36M | 207.02M | 171.7M | 439.6M |
Cash Only | 201.53M | 220.63M | 319.58M | 220.53M | 348.32M | 208.36M | 207.02M | 171.7M | 439.6M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 528.07M | 564.83M | 586.48M | 609.41M | 799.04M | 864.99M | 1.01B | 1.04B | 1.09B |
Days Sales Outstanding | 73.57 | 74.1 | 70.63 | 71.58 | 69.06 | 69.6 | 71.62 | 69.79 | 67.2 |
Inventory | 205.73M | 208.24M | 263.54M | 315.07M | 575M | 604.41M | 674.53M | 581.33M | 631.8M |
Days Inventory Outstanding | 49.17 | 47.29 | 56.22 | 65.18 | 89.67 | 86.33 | 84.3 | 69.42 | 69.68 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 154.41M | 979.25M | 203.77M | 230.4M |
Total Non-Current Assets | 4.21B | 4.02B | 4.22B | 5.36B | 9.54B | 8.81B | 8.19B | 8.15B | 8.34B |
Property, Plant & Equipment | 1.01B | 1.03B | 1.24B | 1.39B | 1.74B | 1.8B | 1.94B | 2.11B | 2.32B |
Fixed Asset Turnover | 2.59x | 2.70x | 2.44x | 2.24x | 2.43x | 2.52x | 2.65x | 2.58x | 2.56x |
Goodwill | 2.43B | 2.32B | 2.36B | 3.03B | 4.4B | 3.88B | 4.07B | 4.1B | 4.19B |
Intangible Assets | 726.98M | 604.61M | 565.47M | 898.41M | 3.33B | 2.08B | 2.12B | 1.85B | 1.62B |
Long-Term Investments | 0 | 0 | 0 | 8.57M | 8.13M | 0 | 0 | 14.3M | 0 |
Other Non-Current Assets | 39.39M | 60.21M | 51.58M | 44.15M | 62.53M | 1.06B | 66.2M | 68.75M | 211.4M |
Total Assets | 5.2B▲ 0% | 5.07B▼ 2.4% | 5.44B▲ 7.2% | 6.57B▲ 20.8% | 11.42B▲ 73.8% | 10.82B▼ 5.3% | 11.06B▲ 2.2% | 10.15B▼ 8.3% | 10.74B▲ 5.8% |
Asset Turnover | 0.50x | 0.55x | 0.56x | 0.47x | 0.37x | 0.42x | 0.46x | 0.54x | 0.55x |
Asset Growth % | 5.6% | -2.45% | 7.25% | 20.84% | 73.76% | -5.27% | 2.23% | -8.29% | 5.82% |
Total Current Liabilities | 398.46M | 465.2M | 503.61M | 577.92M | 922.22M | 861.84M | 931.13M | 1.02B | 1.15B |
Accounts Payable | 135.87M | 152.91M | 149.34M | 156.95M | 225.74M | 264.17M | 251.72M | 280.77M | 338.8M |
Days Payables Outstanding | 32.47 | 34.73 | 31.86 | 32.47 | 35.21 | 37.73 | 31.46 | 33.53 | 37.37 |
Short-Term Debt | 0 | 0 | 0 | 0 | 142.88M | 60M | 85.94M | 125M | 118.9M |
Deferred Revenue (Current) | 31.62M | 55.33M | 53.3M | 62.49M | 110.79M | 85.73M | 70.46M | 57.5M | 0 |
Other Current Liabilities | 207.6M | 219.01M | 243.94M | 271.39M | 323.65M | 331.69M | 418.35M | 447.01M | 687.3M |
Current Ratio | 2.48x | 2.27x | 2.43x | 2.10x | 2.04x | 2.33x | 3.08x | 1.96x | 2.09x |
Quick Ratio | 1.97x | 1.82x | 1.91x | 1.55x | 1.41x | 1.63x | 2.36x | 1.39x | 1.54x |
Cash Conversion Cycle | 90.26 | 86.67 | 94.99 | 104.29 | 123.53 | 118.2 | 124.46 | 105.68 | 99.51 |
Total Non-Current Liabilities | 1.58B | 1.42B | 1.52B | 2.11B | 3.96B | 3.87B | 3.82B | 2.51B | 2.4B |
Long-Term Debt | 1.32B | 1.18B | 1.15B | 1.65B | 2.95B | 3.02B | 3.12B | 1.92B | 1.81B |
Capital Lease Obligations | 0 | 0 | 114.11M | 129.67M | 155.06M | 139.56M | 145.83M | 124.64M | 0 |
Deferred Tax Liabilities | 159.97M | 151.04M | 164.07M | 236.86M | 780.62M | 617.54M | 479.69M | 403.65M | 0 |
Other Non-Current Liabilities | 108.6M | 87.81M | 90.35M | 88.01M | 75.58M | 97.07M | 71.55M | 61.89M | 582.1M |
Total Liabilities | 1.98B | 1.89B | 2.02B | 2.68B | 4.88B | 4.73B | 4.75B | 3.53B | 3.54B |
Total Debt | 1.32B | 1.18B | 1.28B | 1.8B | 3.28B | 3.25B | 3.38B | 2.2B | 1.93B |
Net Debt | 1.11B | 962.59M | 964.86M | 1.58B | 2.93B | 3.04B | 3.18B | 2.03B | 1.49B |
Debt / Equity | 0.41x | 0.37x | 0.38x | 0.46x | 0.50x | 0.53x | 0.54x | 0.33x | 0.27x |
Debt / EBITDA | 2.28x | 1.86x | 1.75x | 2.35x | 3.18x | 2.42x | 2.41x | 1.64x | 1.75x |
Net Debt / EBITDA | 1.93x | 1.51x | 1.31x | 2.06x | 2.84x | 2.26x | 2.27x | 1.51x | 1.35x |
Interest Coverage | 8.01x | 9.20x | 13.38x | 14.92x | 5.10x | 7.14x | 5.87x | 10.23x | 18.15x |
Total Equity | 3.22B▲ 0% | 3.19B▼ 1.0% | 3.42B▲ 7.3% | 3.89B▲ 13.8% | 6.54B▲ 68.2% | 6.09B▼ 7.0% | 6.32B▲ 3.7% | 6.62B▲ 4.8% | 7.2B▲ 8.8% |
Equity Growth % | 14.49% | -0.98% | 7.3% | 13.85% | 68.18% | -6.99% | 3.75% | 4.76% | 8.79% |
Book Value per Share | 37.54 | 37.27 | 39.91 | 45.30 | 66.56 | 60.72 | 63.56 | 66.78 | 72.92 |
Total Shareholders' Equity | 3.21B | 3.18B | 3.41B | 3.88B | 6.53B | 6.08B | 6.3B | 6.6B | 7.2B |
Common Stock | 2.05B | 2B | 1.98B | 2B | 4.74B | 4.49B | 4.54B | 4.42B | 0 |
Retained Earnings | 1.15B | 1.34B | 1.66B | 1.94B | 2B | 1.91B | 2.09B | 2.48B | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 11.69M | -159.78M | -235.46M | -61.24M | -209.81M | -320.71M | -328.66M | -292.34M | 0 |
Minority Interest | 11.34M | 7.99M | 12.85M | 10.48M | 12.28M | 9.97M | 13.18M | 12.35M | 0 |
STE Cash Flow Statement
STERIS plc (STE) cash flow — operating, investing & free cash flow history
| Metric | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 457.63M | 539.5M | 590.56M | 689.64M | 684.81M | 756.95M | 973.27M | 1.15B | 1.34B |
Operating CF Margin % | 17.47% | 19.39% | 19.48% | 22.19% | 16.21% | 16.69% | 18.94% | 21.03% | 22.6% |
Operating CF Growth % | 7.91% | 17.89% | 9.46% | 16.78% | -0.7% | 10.53% | 28.58% | 17.96% | 16.84% |
Net Income | 291.62M | 304.75M | 407.86M | 396.87M | 242.87M | 105.81M | 380.08M | 616.07M | 785.1M |
Depreciation & Amortization | 178.33M | 225.92M | 197.24M | 219.24M | 553.1M | 552.9M | 565.24M | 476.21M | 0 |
Stock-Based Compensation | 22.19M | 23.96M | 23.81M | 25.97M | 57.66M | 38.95M | 56.53M | 57.4M | 0 |
Deferred Taxes | -24.72M | -6.62M | 9.44M | 4.24M | -106.62M | -185.91M | -131.41M | -76.55M | 0 |
Other Non-Cash Items | 49.36M | -18.84M | 2.02M | 24.32M | 87.07M | 495.22M | 248.91M | 8.43M | 529.1M |
Working Capital Changes | -59.15M | 10.34M | -49.81M | 19.01M | -149.28M | -250.02M | -146.08M | 66.51M | 27.2M |
Change in Receivables | -37.73M | -48.49M | -17.87M | 12.08M | -51.97M | -133.3M | -128.07M | -28.82M | 0 |
Change in Inventory | -5.18M | -14.18M | -39.14M | 3.77M | -102.92M | -123.92M | -37.45M | 73.07M | 0 |
Change in Payables | 563K | 21.24M | -2.78M | -7.21M | 14.89M | 53.34M | -18.96M | 33.59M | 0 |
Cash from Investing | -203.83M | -213.22M | -319.74M | -1.15B | -666.56M | -383.33M | -887.36M | 388.77M | -512.5M |
Capital Expenditures | -165.46M | -189.72M | -214.52M | -239.26M | -287.56M | -361.97M | -360.33M | -370.09M | -369M |
CapEx % of Revenue | 6.32% | 6.82% | 7.08% | 7.7% | 6.81% | 7.98% | 7.01% | 6.78% | 6.22% |
Acquisitions | -37.38M | -10.84M | -109.38M | -908.67M | -380.74M | -35.95M | -536.8M | 760.42M | -20.1M |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | -989K | -13.29M | 4.16M | -1.82M | 1.74M | 14.59M | 7.38M | 9.2M | 100K |
Cash from Financing | -356.18M | -294.79M | -163.15M | 345.62M | 115.83M | -498.72M | -85.19M | -1.57B | -568.2M |
Debt Issued (Net) | -193.44M | -112.09M | -26.5M | 484.54M | 372.18M | -6.22M | 121.49M | -1.16B | -122M |
Equity Issued (Net) | -65.48M | -81.49M | -51.24M | -14.65M | -55.78M | -308.56M | -11.77M | -211.32M | -202.6M |
Dividends Paid | -102.93M | -112.5M | -123.03M | -133.84M | -163.17M | -183.5M | -200.57M | -219.88M | -241.8M |
Share Repurchases | -65.48M | -81.49M | -51.24M | -14.65M | -55.78M | -308.56M | -11.77M | -211.32M | -235.5M |
Other Financing | 5.67M | 11.29M | 37.63M | 9.56M | -37.41M | -437K | 5.66M | 23.26M | -1.8M |
Net Change in Cash | -81.38M▲ 0% | 19.1M▲ 123.5% | 98.95M▲ 418.1% | -99.05M▼ 200.1% | 127.79M▲ 229.0% | -139.96M▼ 209.5% | -1.34M▲ 99.0% | -35.32M▼ 2541.7% | 267.9M▲ 858.5% |
Free Cash Flow | 292.18M▲ 0% | 349.79M▲ 19.7% | 376.04M▲ 7.5% | 450.38M▲ 19.8% | 397.25M▼ 11.8% | 394.98M▼ 0.6% | 612.95M▲ 55.2% | 778M▲ 26.9% | 972.4M▲ 25.0% |
FCF Margin % | 11.15% | 12.57% | 12.41% | 14.49% | 9.41% | 8.71% | 11.93% | 14.25% | 16.38% |
FCF Growth % | 16.32% | 19.72% | 7.51% | 19.77% | -11.8% | -0.57% | 55.19% | 26.93% | 24.99% |
FCF per Share | 3.41 | 4.09 | 4.39 | 5.24 | 4.04 | 3.94 | 6.17 | 7.85 | 9.85 |
FCF Conversion (FCF/Net Income) | 1.57x | 1.77x | 1.45x | 1.74x | 2.81x | 7.07x | 2.57x | 1.87x | 1.71x |
Interest Paid | 48.66M | 0 | 0 | 0 | 84.7M | 108.47M | 142.17M | 89.4M | 0 |
Taxes Paid | 85.63M | 0 | 0 | 0 | 138.38M | 254.66M | 271.27M | 273.61M | 0 |
STE Key Ratios
STERIS plc (STE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 3.76% | 9.65% | 9.5% | 12.35% | 10.87% | 4.67% | 1.69% | 6.1% | 9.51% | 11.37% |
Return on Invested Capital (ROIC) | 4.06% | 7.19% | 7.27% | 9.44% | 8.34% | 4.79% | 6.38% | 6.74% | 7.17% | 9.53% |
Gross Margin | 39.28% | 41.71% | 42.23% | 43.55% | 43.22% | 44.59% | 43.66% | 43.17% | 44.01% | 44.25% |
Net Margin | 4.21% | 11.1% | 10.93% | 13.45% | 12.79% | 5.77% | 2.36% | 7.36% | 11.26% | 13.23% |
Debt / Equity | 0.53x | 0.41x | 0.37x | 0.38x | 0.46x | 0.50x | 0.53x | 0.54x | 0.33x | 0.27x |
Interest Coverage | 5.15x | 8.01x | 9.20x | 13.38x | 14.92x | 5.10x | 7.14x | 5.87x | 10.23x | 18.15x |
FCF Conversion | 3.86x | 1.57x | 1.77x | 1.45x | 1.74x | 2.81x | 7.07x | 2.57x | 1.87x | 1.71x |
Revenue Growth | 16.71% | 0.28% | 6.19% | 8.94% | 2.53% | 35.91% | 7.41% | 13.28% | 6.24% | 8.73% |
Related:STE Dividend History·STE Revenue History·STE Price History·STE P/E History·STE Financial Ratios·STE Institutional Holders
STE SEC Filings & Documents
STERIS plc (STE) SEC filings — annual & quarterly reports (10-K, 10-Q)
STE Frequently Asked Questions
STERIS plc (STE) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
STERIS plc (STE) reported $5.94B in revenue for fiscal year 2026. This represents a 910% increase from $587.9M in 1997.
STERIS plc (STE) grew revenue by 8.7% over the past year. This is steady growth.
Yes, STERIS plc (STE) is profitable, generating $782.4M in net income for fiscal year 2026 (13.2% net margin).
Dividend & Returns
Yes, STERIS plc (STE) pays a dividend with a yield of 1.21%. This makes it attractive for income-focused investors.
STERIS plc (STE) has a return on equity (ROE) of 11.4%. This is reasonable for most industries.
STERIS plc (STE) generated $972.4M in free cash flow for fiscal year 2026. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.